Kenneth Frazier - Merck Insider

Merck Co Inc -- USA Stock  

USD 55.2  0.03  0.0544%

Chairman, CEO and Pres

Mr. Kenneth C. Frazier is the Chairman of the Board, President and Chief Executive Officer of the Company. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company and Merck Sharp Dohme Corporationration
Age: 61  Chairman Since 2011      
908 735-1500  www.merck.com
Frazier also served as Executive Vice President and General Counsel of Merck Sharp & Dohme Corporationrationration . Director, Exxon Mobil Corporationrationrationration since 2009 and Pharmaceutical Research and Manufacturers of America since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Management Efficiency

The company has Return on Asset of 7.18 % which means that on every $100 spent on asset it made $7.18 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 12.29 % implying that it generated $12.29 on every 100 dollars invested.
The company has 24.91 B in debt with debt to equity (D/E) ratio of 62.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Merck Co Inc has Current Ratio of 1.47 which is typical for the industry and considered as normal.

Similar Executives

Found 7 records

CHAIRMAN Since

Roger KimmelEndo International plc
2007
Miles WhiteAbbott Laboratories
1999
Dennis GillingsQuintiles IMS Holdings Inc
2016
Jeffrey LeidenVertex Pharmaceuticals Incorpor
2012
Norman SchwartzBio Rad Laboratories Inc
2012
Paul BisaroAllergan plc
2016
Joshua BogerVertex Pharmaceuticals Incorpor
2009

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio

Top Management

Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Richard DeLuca, President
Kenneth Frazier, Chairman

Stock Performance

Merck Performance Indicators